13D/13G Filings - Eventide Asset Management, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
11:43 am
Sale
2021-12-31 13G Entasis Therapeutics Holdings Inc.
ETTX
Eventide Asset Management, LLC 590,602
1.200%
-288,939decrease
(-32.85%)
Filing
History
2022-02-14
11:41 am
Purchase
2021-12-31 13G Zymeworks Inc.
ZYME
Eventide Asset Management, LLC 2,819,135
6.100%
2,819,135increase
(New Position)
Filing
History
2022-02-14
11:39 am
Purchase
2021-12-31 13G Annexon, Inc.
ANNX
Eventide Asset Management, LLC 2,850,000
7.400%
845,384increase
(+42.17%)
Filing
History
2022-02-14
11:37 am
Purchase
2021-12-31 13G VectivBio Holding AG
VECT
Eventide Asset Management, LLC 2,339,044
6.700%
2,339,044increase
(New Position)
Filing
History
2022-02-14
11:35 am
Purchase
2021-12-31 13G Prometheus Biosciences, Inc.
RXDX
Eventide Asset Management, LLC 3,742,507
9.600%
3,742,507increase
(New Position)
Filing
History
2022-02-14
11:33 am
Purchase
2021-12-31 13G Cogent Biosciences, Inc.
COGT
Eventide Asset Management, LLC 3,514,909
8.800%
3,514,909increase
(New Position)
Filing
History
2022-02-10
4:18 pm
Purchase
2022-01-31 13G KnowBe4, Inc.
KNBE
Eventide Asset Management, LLC 4,177,983
10.100%
4,177,983increase
(New Position)
Filing
History
2021-02-12
4:19 pm
Purchase
2020-12-31 13G ESSA Pharma Inc.
EPIX
Eventide Asset Management, LLC 2,335,168
7.000%
324,999increase
(+16.17%)
Filing
History
2021-02-12
4:16 pm
Sale
2020-12-31 13G ARYA SCIENCES ACQUISITION CORP
ARYAU
Eventide Asset Management, LLC 0
0.000%
-800,000decrease
(Position Closed)
Filing
History
2021-02-12
4:15 pm
Sale
2020-12-31 13G Magenta Therapeutics, Inc.
MGTA
Eventide Asset Management, LLC 1,000,000
2.100%
-2,393,894decrease
(-70.54%)
Filing
History
2021-02-12
4:13 pm
Sale
2020-12-31 13G STEMLINE THERAPEUTICS INC
STML
Eventide Asset Management, LLC 0
0.000%
-4,160,608decrease
(Position Closed)
Filing
History
2021-02-12
4:13 pm
Purchase
2020-12-31 13G Vital Farms, Inc.
VITL
Eventide Asset Management, LLC 2,053,232
5.200%
2,053,232increase
(New Position)
Filing
History
2021-02-12
4:11 pm
Purchase
2020-12-31 13G Praxis Precision Medicines, Inc.
PRAX
Eventide Asset Management, LLC 234,205
9.200%
234,205increase
(New Position)
Filing
History
2021-02-12
4:11 pm
Purchase
2020-12-31 13G Pliant Therapeutics, Inc.
PLRX
Eventide Asset Management, LLC 2,838,125
8.000%
2,838,125increase
(New Position)
Filing
History
2021-02-12
4:10 pm
Purchase
2020-12-31 13G Sutro Biopharma, Inc.
STRO
Eventide Asset Management, LLC 2,370,975
5.300%
1,126,080increase
(+90.46%)
Filing
History
2021-02-12
4:08 pm
Purchase
2020-12-31 13G Kala Pharmaceuticals, Inc.
KALA
Eventide Asset Management, LLC 138,000
6.200%
138,000increase
(New Position)
Filing
History
2021-02-12
4:07 pm
Sale
2020-12-31 13G Zogenix, Inc.
ZGNX
Eventide Asset Management, LLC 0
0.000%
-2,841,300decrease
(Position Closed)
Filing
History
2021-02-12
4:07 pm
Purchase
2020-12-31 13G Freeline Therapeutics Holdings plc
FRLN
Eventide Asset Management, LLC 165,710
7.500%
165,710increase
(New Position)
Filing
History
2021-02-12
4:06 pm
Purchase
2020-12-31 13G Chiasma, Inc.
CHMA
Eventide Asset Management, LLC 3,000,326
5.200%
3,000,326increase
(New Position)
Filing
History
2021-02-12
4:05 pm
Purchase
2020-12-31 13G Annexon, Inc.
ANNX
Eventide Asset Management, LLC 2,004,616
5.300%
2,004,616increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3